• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: HOLOGIC, INC MYOSURE TISSUE REMOVAL DEVICE; HYSTEROSCOPE (AND ACCESSORIES)

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

HOLOGIC, INC MYOSURE TISSUE REMOVAL DEVICE; HYSTEROSCOPE (AND ACCESSORIES) Back to Search Results
Model Number 50-501XL
Device Problem Use of Device Problem (1670)
Patient Problems Vaginal Mucosa Damage (2124); Appropriate Clinical Signs, Symptoms, Conditions Term / Code Not Available (4581)
Event Type  Injury  
Manufacturer Narrative
Adverse event health effect : proposed code urethral injury.Lot and serial number of the device not provided by the complainant; therefore, the udi, expiration and manufacturing dates are not known.Device history record (dhr) review was unable to be conducted for the disposable device as the identification numbers were not provided by the complainant.The device involved in this event was not returned for evaluation purposes therefore visual and functional analysis of the product could not be performed.We are unable to confirm a relationship between the device and the issue reported and a definitive root cause for the reported event could not be determined.The information obtained during complaint investigation will be included in our global complaint trending and product surveillance will continue to monitor complaints of this type for adverse trends.If the product is received or additional information is obtained, the investigation will be reopened accordingly per standard operating procedure.
 
Event Description
It was reported that a 44 years old patient underwent a myosure ablation procedure in (b)(6) 2023 / (b)(6) 2023.The device was successfully tested testing prior to use and it was used in the procedure without any malfunctions.However, at the end of the procedure, the disposable device was not removed prior to the hysteroscope removal as expected: when removing the hysteroscope, the device was still within the hysteroscope and was protruding through the distal end of the hysteroscope.The surgeon¿s foot was either still on the foot pedal and/or she pressed the foot pedal on removing the instrumentation.As a result on removal, the myosure device resected vaginal tissue which lead to anterior vaginal wall and urethral damage.A surgical repair was immediately required and the patient has been catheterized which is to remain in-situ for 3-months.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
MYOSURE TISSUE REMOVAL DEVICE
Type of Device
HYSTEROSCOPE (AND ACCESSORIES)
Manufacturer (Section D)
HOLOGIC, INC
250 campus drive
marlborough MA 01752
Manufacturer (Section G)
HOLOGIC, INC.
250 campus drive
marlborough MA 01752
Manufacturer Contact
daniel guevara
562 parkway
coyol free zone building b24
san jose 20102
CR   20102
MDR Report Key16473276
MDR Text Key310561269
Report Number1222780-2023-00054
Device Sequence Number1
Product Code HIH
UDI-Device Identifier15420045505094
UDI-Public15420045505094
Combination Product (y/n)N
Reporter Country CodeUK
PMA/PMN Number
K142029
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,User Facility,Company Representative
Reporter Occupation Non-Healthcare Professional
Type of Report Initial
Report Date 03/02/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received03/02/2023
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model Number50-501XL
Device Catalogue Number50-501XL
Was Device Available for Evaluation? No
Date Manufacturer Received02/14/2023
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Other;
-
-